Marigold Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 14 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth 6.15%
- Profit Growth 122.97%
- Ebitda -5.16%
- Net Worth 6.10%
- Total Assets 81.38%
About Marigold Pharmaceuticals
Marigold Pharmaceuticals Private Limited (MPPL) is a Private Limited Indian Non-Government Company incorporated in India on 21 April 2010 and has a history of 14 years and nine months. Its registered office is in Solapur, Maharashtra, India.
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Bhagirathibai Babasaheb and Shivabai Chandwad serve as directors at the Company.
Company Details
- Location
Solapur, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media-
Corporate Identity Details
- CIN/LLPIN
U24231PN2010PTC136126
- Company No.
136126
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
21 Apr 2010
- Date of AGM
15 Nov 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Who are the key members and board of directors at Marigold Pharmaceuticals?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Bhagirathibai Babasaheb  | Director | 23-Apr-2019 | Current |
| Shivabai Chandwad | Director | 07-May-2014 | Current |
Financial Performance of Marigold Pharmaceuticals.
Marigold Pharmaceuticals Private Limited, for the financial year ended 2020, experienced modest growth in revenue, with a 6.15% increase. The company also saw a substantial improvement in profitability, with a 122.97% increase in profit. The company's net worth moved up by a moderate rise of 6.1%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Marigold Pharmaceuticals?
Unlock access to Marigold Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Marigold Wellness Private LimitedBhagirathibai Babasaheb and Shivabai Chandwad are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Marigold Pharmaceuticals?
Unlock and access historical data on people associated with Marigold Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Marigold Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Marigold Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
